Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1331|25|1|97-104

ISSN： 1351-5101

Source： EUROPEAN JOURNAL OF NEUROLOGY, Vol.25, Iss.1, 2018-01, pp. : 97-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypermetabolism appears to be an adverse prognostic biomarker in amyotrophic lateral sclerosis: a potential for therapeutic intervention?

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 1-2

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pre‐morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis

By  

MUSCLE AND NERVE, Vol. 52, Iss. 3, 2015-09 ,pp. : 339-343

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pre‐morbid type 2 diabetes mellitus as a prognostic factor in amyotrophic lateral sclerosis

By  

MUSCLE AND NERVE, Vol. 148-639X, Iss. 4, 2015-10 ,pp. : 690-691

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pre‐morbid type 2 diabetes mellitus as a prognostic factor in amyotrophic lateral sclerosis

By  

MUSCLE AND NERVE, Vol. 52, Iss. 4, 2015-10 ,pp. : 690-691

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 3, 2015-09 ,pp. : 212-215

John Wiley & Sons Inc

Access to resources Recommend Favorite